A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Valued to be $3.3 Billion by 2026, Cervical Total Disc Replacement Devices Slated for Robust Growth Worldwide

A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled “Cervical Total Disc Replacement Devices – Global Market Trajectory & Analytics”. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
Edition: 8; Released: April 2021
Executive Pool: 5553
Companies: 42 – Players covered include DePuy Synthes; Globus Medical, Inc.; Medtronic PLC; NuVasive, Inc.; Zimmer Biomet Holdings, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Segment (Cervical Total Disc Replacement Device)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Cervical Total Disc Replacement Devices Market to Reach $3.3 Billion by 2026
Amid the COVID-19 crisis, the global market for Cervical Total Disc Replacement Devices estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2026, growing at a CAGR of 19.9% over the analysis period.

The U.S. Market is Estimated at $405.3 Million in 2021, While China is Forecast to Reach $582.5 Million by 2026
The Cervical Total Disc Replacement Devices market in the U.S. is estimated at US$405.3 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$582.5 Million by the year 2026 trailing a CAGR of 19.5% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.7% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include – enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy